Beyond Bispecifics: Tetraspecific T Cell Engagers to Enhance T Cell Activation & Overcome Tumor Heterogeneity & Antigen Loss
- A modular tetraspecific antibody platform to maximize the “power of multispecifics” and target complex diseases
- Combining CD3 and CD28 to mimic physiological T cell activation and promote optimal T cells survival and function
- Targeting two tumor antigens with one molecule to address tumor heterogeneity and minimize escape